Highlights
TSXV: AQS       Aequus Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
0.17   0.00 (0.00%)  0.16 - 0.17  42,000

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.13 - 0.17
52 Weeks Price Volatility (%):
100.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products. The Company operates through the segment of sales and marketing of pharmaceutical drugs developed by the Company or by its collaborative partners. Its products include tacrolimus immediate releaser, which is an immunosuppressive therapy used for the treatment and prevention of acute rejection following organ transplantation; Vistitan, which is a ophthalmology product; Topiramate extended-release (XR), which is a once-daily topiramate product designed for patient compliance, and Oxcarbazepine XR, which is a once-daily oxcarbazepine product. Its development-stage pipeline includes various products in neurology and psychiatry. Its lead development-stage product candidate is AQS-1301. In addition, the Company is developing a pipeline of other central nervous system product candidates. It has over two preclinical-stage programs and a clinical-stage program in development.

  Be the first to like this.
 


 

721  922  1225  1685 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ACB 3.00-0.59 
 ECA 5.50-0.26 
 APHA 5.03-0.62 
 PXI 0.065+0.005 
 TGOD 0.65-0.05 
 OGC 2.66+0.06 
 WEED 18.78-1.51 
 CPG 5.21-0.08 
 BTO 4.77+0.14 
 PEY 2.86-0.18 
Partners & Brokers